Q-omics provides the consensus-scored MTCYBP14 profile across patient tissues and cancer cell-line models. MTCYBP14 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MTCYBP14 RNA expression shows 6,288 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where MTCYBP14 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTCYBP14 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTCYBP14 survival associations across molecular data types. MTCYBP14 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTCYBP14 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	STAD (54)	view →

This table ranks reproducible MTCYBP14 RNA expression–survival associations across cancer types. High MTCYBP14 expression shows unfavorable associations in STAD, UCEC, GBM, OV, BLCA and THCA. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify STAD as the clearest survival context for MTCYBP14 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.498	0.764	.003	54	view →
UCEC	OS	Tertile	III,IV	0.695	0.844	.008	42	view →
GBM	OS	Tertile	All	0.184	0.424	<.001	36	view →
OV	OS	Tertile	IV	0.083	0.759	.027	36	view →
BLCA	OS	Tertile	III,IV	0.368	0.688	.006	27	view →
THCA	DFS	Tertile	IV	0.146	0.795	.004	18	view →

Pink = unfavorable, green = favorable. all 8 lineages →

MTCYBP14-STAD (OS)

Kaplan–Meier survival curve for MTCYBP14 RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTCYBP14 in patient tissues and cancer cell lines. In patient samples, MTCYBP14 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,288	STAD (6090)	view →
Protein (mass-spec)	3,671	GBM (3316)	view →